Search

Your search keyword '"Syem K, Barakzai"' showing total 4 results
Start Over "Syem K, Barakzai" Publication Type Magazines
4 results on '"Syem K, Barakzai"'

1. Research from Harvard Medical School in Ovarian Cancer Provides New Insights (Abstract 7557: Hypoxia-induced downregulation of MUC16: A key player in bispecific T-cell engager resistance in ovarian cancer).

Subjects
OVARIAN cancer, MEDICAL schools, T cells, DOWNREGULATION
Abstract

A recent report from Harvard Medical School discusses research on ovarian cancer and the potential resistance to bispecific T-cell engager (BiTE) therapy. The study focused on the role of hypoxia in the modulation of MUC16, a protein associated with ovarian cancer, and its impact on resistance to BiTE therapy. The researchers found that hypoxia led to a decrease in MUC16 expression on tumor cells, as well as changes in epithelial-mesenchymal transition (EMT) markers and the upregulation of epidermal growth factor receptor (EGFR). Understanding these mechanisms could provide valuable insights into BiTE therapy resistance in ovarian cancer. [Extracted from the article]

Published
2024

2. Investigators at Massachusetts General Hospital Report Findings in Ovarian Cancer (The Association of Maintenance Hormone Therapy With Overall Survival In Advanced-stage Low-grade Serous Ovarian Carcinoma: a Risk-set Matched Retrospective Study).

Subjects
GYNECOLOGIC oncology, HORMONE therapy, PROPENSITY score matching, ACADEMIC medical centers, OVERALL survival, OVARIAN cancer
Abstract

A recent study conducted at Massachusetts General Hospital investigated the association between maintenance hormone therapy and overall survival in patients with low-grade advanced-stage ovarian cancer. The study found that patients who received hormone therapy within six months of diagnosis had a reduced risk of death compared to those who did not receive hormone therapy. This research suggests that maintenance hormone therapy may be beneficial for improving overall survival in patients with low-grade advanced-stage ovarian cancer. [Extracted from the article]

Published
2024

3. Research from Harvard Medical School in Ovarian Cancer Provides New Insights (Abstract 7557: Hypoxia-induced downregulation of MUC16: A key player in bispecific T-cell engager resistance in ovarian cancer)

Subjects
Oncology, Experimental, Women -- Health aspects, T cells -- Research, Drug resistance in microorganisms -- Research, Ovarian cancer -- Research, Cancer -- Research, Health, Women's issues/gender studies, Harvard University. Harvard Medical School
Abstract

2024 APR 11 (NewsRx) -- By a News Reporter-Staff News Editor at Women's Health Weekly -- Research findings on ovarian cancer are discussed in a new report. According to news [...]

Published
2024

4. Data on Ovarian Cancer Described by Researchers at University of Southern California (USC) (Utilization of Sentinel Lymph Node Biopsy In the Early Ovarian Cancer Surgery)

Subjects
Oncology, Experimental, Women -- Health aspects, Cancer -- Research, Ovarian cancer -- Research, Surgery -- Research, Health, Women's issues/gender studies, University of Southern California
Abstract

2022 JUN 23 (NewsRx) -- By a News Reporter-Staff News Editor at Women's Health Weekly -- Investigators discuss new findings in Oncology - Ovarian Cancer. According to news reporting originating [...]

Published
2022

Catalog

Books, media, physical & digital resources
See catalog results